Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Change in Accured Expenses (2020 - 2025)

Candel Therapeutics' Change in Accured Expenses history spans 4 years, with the latest figure at $946000.0 for Q4 2023.

  • On a quarterly basis, Change in Accured Expenses rose 117.47% to $946000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was -$301000.0, a 123.79% decrease, with the full-year FY2025 number at $2.3 million, up 197.75% from a year prior.
  • Change in Accured Expenses hit $946000.0 in Q4 2023 for Candel Therapeutics, up from -$85000.0 in the prior quarter.
  • Over the last five years, Change in Accured Expenses for CADL hit a ceiling of $1.4 million in Q4 2020 and a floor of -$1.8 million in Q1 2023.
  • Historically, Change in Accured Expenses has averaged $198714.3 across 4 years, with a median of $310500.0 in 2022.
  • Biggest five-year swings in Change in Accured Expenses: surged 510.61% in 2021 and later crashed 2088.89% in 2023.
  • Tracing CADL's Change in Accured Expenses over 4 years: stood at $1.4 million in 2020, then plummeted by 48.24% to $719000.0 in 2021, then crashed by 39.5% to $435000.0 in 2022, then soared by 117.47% to $946000.0 in 2023.
  • Business Quant data shows Change in Accured Expenses for CADL at $946000.0 in Q4 2023, -$85000.0 in Q3 2023, and $628000.0 in Q2 2023.